Russia Blood Glucose Monitoring Market Size, Share, and COVID-19 Impact Analysis, By Type (Self-Monitoring Blood Glucose, and Continuous Glucose Monitoring), By End User (Hospitals, Home Care, and Diagnostic Centers), and Russia Blood Glucose Monitoring Market Insights, Industry Trend, Forecasts to 2033

Industry: Healthcare

RELEASE DATE Oct 2024
REPORT ID SI6791
PAGES 231
REPORT FORMAT PathSoft

Russia Blood Glucose Monitoring Market Insights Forecasts to 2033

  • The Russia Blood Glucose Monitoring Market Size was valued at USD 485.30 Million in 2023
  • The Market is Growing at a CAGR of 8.85% from 2023 to 2033
  • The Russia Blood Glucose Monitoring Market Size is Expected to Reach USD 1132.85 Million by 2033

Russia Blood Glucose Monitoring Market

Get more details on this report -

Request Free Sample PDF

The Russia Blood Glucose Monitoring Market Size is Anticipated to Reach USD 1132.85 Million by 2033, Growing at a CAGR of 8.85% from 2023 to 2033.

 

Market Overview

Blood glucose monitoring facilitates the identification of trends in blood glucose fluctuations resulting from dietary changes, physical activity, medication interactions, and pathological processes like diabetes mellitus. Blood glucose levels that are abnormally high or low have the potential to cause acute and chronic diseases that are potentially fatal. Venous blood testing for plasma glucose and CBG are two types of blood glucose tests that are carried out in hospitals.  Blood glucose monitoring (BGM) is essential for providing several forms of support to people with diabetes. The introduction of new products and growing awareness of diabetes-preventative strategies are the main drivers of market growth. Older persons are more likely to develop diabetes or experience problems from the condition, as the prevalence of the disease tends to rise with age. The number of people at risk of diabetes rises with the aging population, increasing the need for blood glucose monitoring equipment.     

 

Report Coverage

This research report categorizes the market for the Russia blood glucose monitoring market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Russia blood glucose monitoring market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Russia blood glucose monitoring market.

 

Russia Blood Glucose Monitoring Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 485.30 Million
Forecast Period:2023 - 2033
Forecast Period CAGR 2023 - 2033 :8.85%
2033 Value Projection:USD 1132.85 Million
Historical Data for:2019-2022
No. of Pages:231
Tables, Charts & Figures:98
Segments covered:By Type, By End User and COVID-19 Impact Analysis.
Companies covered:: Roche, Abbott, Dexcom, Medtech, Medtronics, LifeScan, and other key vendors.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The blood glucose monitoring device market has grown as a result of significant technological innovation. The market is growing due to two factors: an increase in the number of people with diabetes and a rise in the introduction of novel products. One of the primary causes of the growing patient pool that needs routine blood glucose monitoring is the increasing prevalence of diabetes in the general population. The increased prevalence of diabetes is mainly due to factors like fast urbanization and the trend toward sedentary lifestyles that are propelling the market. The market for blood glucose monitors is anticipated to grow as a result of the government's increased efforts to raise awareness about diabetes prevention.

 

Restraining Factors

The market for blood glucose monitoring is only being adopted to a limited extent due to the expensive cost of monitoring equipment and the low reimbursement, particularly inside the nation.

 

Market Segmentation

The Russia blood glucose monitoring market share is classified into type and end user

  • The self-monitoring blood glucose segment is expected to hold the largest market share through the forecast period.

The Russia blood glucose monitoring market is segmented by product type into self-monitoring blood glucose and continuous glucose monitoring. Among these, the self-monitoring blood glucose segment is expected to hold the largest market share through the forecast period. The self-monitoring blood glucose is due to its low cost and easy use. Self-monitoring of blood glucose (SMBG), which measures blood sugar levels with a glucose meter, is an essential part of managing diabetes daily. In addition, several SMBG tools such as lancets and testing strips are employed for the individual management of glucose levels. 

    

  • The home care segment is expected to dominate the Russia blood glucose monitoring market during the forecast period.       

Based on the end user, the Russia blood glucose monitoring market is divided into hospitals, home care, and diagnostic centers. Among these, the home care segment is expected to dominate the Russia blood glucose monitoring market during the forecast period. Preventive healthcare is becoming more and more important in Russia, as it promotes early diagnosis and treatment of illnesses. Continuous monitoring in-home care settings enables people to identify and manage changes in blood glucose levels comfortably and conveniently at home.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Russia blood glucose monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Roche
  • Abbott
  • Dexcom
  • Medtech
  • Medtronics
  • LifeScan
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments

  • In October 2023, Phillips-Medisize, a Molex company, and a leader in the design, engineering, and manufacturing of pharmaceutical drug delivery, invitro diagnostic, and medtech devices, has partnered with GlucoModicum, an innovative medtech company based in Finland, to develop and eventually market a proprietary non-invasive wearable device that eliminates patient care and technological barriers to continuous glucose monitoring (CGM).   

 

Market Segment

This study forecasts revenue at Russia, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Russia blood glucose monitoring market based on the below-mentioned segments:

 

Russia Blood Glucose Monitoring Market, By Type

  • Self-Monitoring Blood Glucose
  • Continuous Glucose Monitoring

 

Russia Blood Glucose Monitoring Market, By End User

  • Hospitals
  • Home Care
  • Diagnostic Centers

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies